Tag: neurometrix

January 30, 2019

NeuroMetrix Reports New Clinical Studies Published on DPNCheck

NeuroMetrix (Nasdaq:NURO) reported publication of three new DPNCheck clinical studies. DPNCheck is a point-of-care test that provides accurate and cost-effective screening,...
January 23, 2019

NeuroMetrix Reports Publication of Randomized Controlled Trial of Quell Wearable Pain Relief in Chronic Low Back Pain

NeuroMetrix (Nasdaq:NURO) reported publication of results from a randomized controlled trial of Quell in subjects with chronic low back pain in...
December 28, 2018

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

NeuroMetrix (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,159,835 titled “Detecting cutaneous...
December 20, 2018

NeuroMetrix to Present at Upcoming Biotech Showcase 2019 In San Francisco

NeuroMetrix, Inc. (Nasdaq:NURO) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the Biotech...
December 12, 2018

NeuroMetrix Reports Agreement with GSK Healthcare on 2019 Quell Joint Development Program and Modification to Strategic Collaboration

NeuroMetrix (Nasdaq:NURO) today reported momentum in its strategic collaboration with GSK Consumer Healthcare. As quoted in the press release: Under...
November 20, 2018

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

NeuroMetrix (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,130,810 titled “Transcutaneous electrical...
November 16, 2018

NeuroMetrix Announces DPNCheck Collaboration Agreement with Fukuda Denshi for Japan Market

NeuroMetrix (Nasdaq:NURO), announced today that it had executed a distribution agreement with Fukuda Denshi for DPNCheck, the Company’s  rapid, point-of-care...